U.S. markets closed

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.8856-0.0628 (-6.62%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 4/5/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.37
52-Week Change 3147.22%
S&P500 52-Week Change 349.51%
52 Week High 32.3400
52 Week Low 30.3200
50-Day Moving Average 31.0165
200-Day Moving Average 30.8655

Share Statistics

Avg Vol (3 month) 318.7M
Avg Vol (10 day) 32.44M
Shares Outstanding 5140.28M
Implied Shares Outstanding 6N/A
Float 92.97M
% Held by Insiders 10.63%
% Held by Institutions 14.30%
Shares Short (Mar 14, 2021) 44.03M
Short Ratio (Mar 14, 2021) 40.51
Short % of Float (Mar 14, 2021) 42.89%
Short % of Shares Outstanding (Mar 14, 2021) 42.87%
Shares Short (prior month Feb 11, 2021) 44.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:17
Last Split Date 3Dec 12, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin -188.31%
Operating Margin (ttm)-157.94%

Management Effectiveness

Return on Assets (ttm)-37.61%
Return on Equity (ttm)-102.54%

Income Statement

Revenue (ttm)18.43M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)-27.10%
Gross Profit (ttm)6.31M
EBITDA -25.62M
Net Income Avi to Common (ttm)-34.71M
Diluted EPS (ttm)-0.4990
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.38M
Total Cash Per Share (mrq)0.13
Total Debt (mrq)6.88M
Total Debt/Equity (mrq)25.11
Current Ratio (mrq)1.32
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)-18.43M
Levered Free Cash Flow (ttm)-9.41M